We report the first conditional SIK1 knockout mouse models.
Global and muscle-specific SIK1-KO mice are insulin sensitive on HFD.
Liver- and fat-specific SIK1-KO mice are normoglycemic.
SIK1 expression increases in skeletal muscle of obese mice.
SIK1 is a promising therapeutic target to improve insulin sensitivity in obesity.